Model industry enters a dangerous new era: glp-1s fuel a return to extreme thinness
The modeling world is facing a troubling shift: a rapid return to unnervingly thin physiques, fueled by the widespread use of GLP-1 weight-loss medications. From the cramped apartments of yesteryear to the high-stakes runways of today, the pressure to conform – and now, to drastically slim down – is intensifying.
A toxic cycle of obsession
Samantha Benjamin, a former model who witnessed firsthand the industry’s relentless pursuit of extreme thinness, describes a chilling pattern: “Girls are getting called fat. Nobody is mincing words.” The rise of drugs like Ozempic and Wegovy isn’t simply offering a Health benefit; it’s creating a new, potentially dangerous standard, one where a surgically-induced, or medication-assisted, thinness is seemingly required for success.
The runway’s shocking transformation
Industry insiders are observing a stark trend. “Models have definitely gotten smaller,” notes Zoe Latta of Eckhaus Latta. “I think it’s a combination of GLP-1s and a pendulum swing to extreme thinness being an idealized look again.” The data backs it up: the Fall-Winter 2026 Vogue Business size inclusivity report reveals a dramatic decline in representation for both mid- and plus-size models, hitting their lowest levels in three years. The allure of these medications is proving irresistible, with one in eight Americans now utilizing GLP-1s.
A shadow of abuse
But the narrative isn’t purely one of wellness. A major model agent privately admits, “It’s almost like the new-millennia cocaine.” The ease of access, coupled with a desire to meet increasingly stringent demands, has created a climate of potential abuse. Brooks Nader, a model who’s openly discussed her use of Ozempic, recounts a disconcerting experience: “When I lost weight, I started to confirm a lot more work.”
Lost momentum, shifting standards
Previous efforts to promote inclusivity – from BMI reforms after the 2006 and 2007 model deaths to Kering and LVMH’s ‘model charter’ – seem to be losing ground. As Mina White, a director at IMG Models, observes, “We’ve gone back to skinny girls, it’s because that is what the people who are running these houses and their casting directors and their stylists are dictating.” The industry’s obsession with uniformity is diminishing the unique character that once defined successful models, transforming it into a homogenized, bordering on sterile, aesthetic. “It’s homogenized; it’s not interesting; it’s the same as everybody having veneers,” Benjamin states bluntly.
A cruel irony
Interestingly, some curve models are actively seeking these medications, driven by a desire to meet the current industry standard and secure more opportunities. However, they’re increasingly concerned about the potential repercussions, fearing a decline in bookings. “I feel too big for this industry sometimes,” says Grace Breuning, a curve model who has walked in Chanel shows. “I’ve never known thinness, and so seeing girls that looked like me was really important to me.”
The end of a conversation?
Ultimately, the rise of GLP-1s underscores a deeper problem: a persistent and arguably ingrained pressure within the fashion industry to prioritize an impossibly thin ideal. As Ashley Mears, a sociologist studying the modeling world, succinctly puts it, “Everybody’s saying the market gets what it wants, but they are the market.” The industry’s attempts to balance inclusivity with commercially viable trends remain tragically inconsistent. The current trajectory, fueled by fleeting fads and potentially harmful practices, suggests a return to a dangerous and unsustainable status quo.